期刊文献+

2003~2008年卫生部北京医院住院患者氟喹诺酮类药临床应用情况评价与分析 被引量:6

Evaluation and Analysis on the Utilization of Quinolones for the Inpatients of Beijing Hospital of Ministry of Health During 2003~2008
暂未订购
导出
摘要 目的:初步探讨医院抗菌药物合理应用的评价方法,以病原微生物耐药率作为评价指标,考察氟喹诺酮类合理应用的可行性,优化医院抗菌药物的应用。方法:对我院2003~2008年6年间氟喹诺酮类药使用情况进行统计分析,结合我院病原微生物的耐药性情况进行评价。结果:总体来说,我院氟喹诺酮类药的应用相对稳定,不同品种的使用频率与细菌耐药情况基本一致。但是发现,药品使用量也与临床对国内外指南的重视程度有关,如受美国感染病学会/美国胸科学会(IDSA/ATS)的CAP指南推荐的影响,近年来莫西沙星的使用率上升,而耐药率逐渐升高的左氧氟沙星使用率有下降趋势。结论:临床应该重视氟喹诺酮类药的合理应用,同时要重视普通病房感染病例的细菌耐药性检测,提高送检率,以获得全院关于病原微生物流行病学的全面资料,有利于促进抗感染药的合理应用。 OBJECTIVE: To explore the method for evaluating the rational utilization of antibiotics in hospital,and to discuss the feasibility of rational use of quinolones using bacterial drug resistance as index so as to optimize the use of antibiotics in hospital. METHODS: The utilization of quinolones in our hospital from 2003 to 2008 were statistically analyzed and evaluated based on the data of bacterial drug resistance in our hospital. RESULTS: Generally,the utility of quinolones in our hospital was relative stable,with a conformity noted between the medication frequency of quinolones and the bacterial drug resistance level. However,the consumption amount of quinolones was also associated with the degree of the importance attached to the related guidelines both at home and abroad,for example,influenced by the IDSA/ATS Guidelines on the Management of Community - Acquired Pneumonia in Adults,the consumption of moxifloxacin has been increasing recently while the consumption of levofloxacin has been declining. CONCLUSION: Great importance should be attached to clinical rational use of quinolones as well as the bacterial drug resistance test of cases in general wards so as to increase the bacterial drug resistance test rate and gain the epidemiological data of pathogenic microorganisms in general wards because it is conducive to rational use of anti - infective drugs.
出处 《中国医院用药评价与分析》 2010年第3期201-203,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
基金 卫生部北京医院院内(局级)课题 卫生行业科研专项(200902008-03)
关键词 氟喹诺酮类药物 评价与分析 左氧氟沙星 细菌耐药 Quinolones Evaluation and analysis Levofloxacin Bacterial drug resistance
  • 相关文献

参考文献3

二级参考文献31

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:792
  • 3张璟,孙自镛,马越,李景云,金少鸿.152株肺炎链球菌的耐药性及血清分型研究[J].中华医院感染学杂志,2007,17(4):468-471. 被引量:36
  • 4Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Eighteenth informational supplement. CIGI documents M100-S18. CLSI/NCCLS,2008.
  • 5Granger D, Boily-Larouche G, Turgeon P, et al. Molecular characteristics of pbpla and pbp2b in clinical Streptococcus pneurnoniae isolates in Quebec. Canada[J]. J Antimierob Chemoter,2006,57(1):61-70.
  • 6Schwaber MJ, Navon-Venezia S, Kaye KS, et al. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamases-producing Enterobacteriaeeae[J]. Antimierob Agents Chemother, 2006,50(4) : 1257-1262.
  • 7Tumbarello M, Spanu T, Sanguinetti M, et al. Bloodstream infections caused by extended-spectrum-β-lactamases-producing Klebsiella pneumoniae :risk factors, molecular epidemiol- ogy and clinical outcome[J]. Antimicrob Agents Chemother, 2006,50(2):498 504.
  • 8Wang H, Kelkar S, Wu WY, etal. Clinical isolates of Enterobacteriaceae producing extended-spectrum β-lactamases:prevalence of CTX-M 3 at a hospital in China[J]. Antimicrob Agents Chemother, 2003,47(2) : 790-793.
  • 9Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically[S]. Seventh edition. Approved Standard. CLSI documents M7 A7. CLSI,2006.
  • 10Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.

共引文献3416

同被引文献72

  • 1刘芳,赵荣生,李静,李培红,李志琴,张宁,王汝龙,李大魁,薛立宁,贾方红,严静敏.北京市医疗保险神经科住院患者应用醒脑静注射液的回顾性调查[J].临床药物治疗杂志,2006,4(6):47-50. 被引量:4
  • 2白波,常明,李宏,王景红,张昕,沈素,张卫东,王汝龙,李大魁,薛立宁,贾方红,严静敏.北京市医疗保险住院患者康莱特注射液用药情况的调研与分析[J].临床药物治疗杂志,2006,4(6):42-46. 被引量:4
  • 3高晨,赵志刚,徐春敏,王汝龙,李大魁,薛立宁,贾方红,严静敏,高淑艳,梅娜,辛艳如,杨京艳,陈放,赵京春,牛金苹,张彦文,张锐.北京市医疗保险住院患者灯盏细辛、灯盏花素注射剂用药情况调查与分析[J].临床药物治疗杂志,2007,5(2):42-46. 被引量:6
  • 4李静,钟秀玲,张藜莉,范超云,柳景华,张斌,李小瑛,岳志刚,吴克华,孟坤,焦建辉,陶维良.我院住院患者抗菌药物的合理应用[J].中国药房,2007,18(11):827-829. 被引量:1
  • 5卫生部办公厅.关于抗菌药物临床应用管理有关问题的通知[S].卫办医政发[2009]38号.
  • 6EDWARD D,FROHLICH M D, MAC P. Generic drugs: the good, the bad, and the unknown [ J ]. Ochsner J,2011, 11(2) :98.
  • 7WISOFF T , SELMER R M, HALVORSENO S, et al. Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis [ J ]. BMC Cardiovasc Disord, 2012, 12 (26) : in press.
  • 8AMIDON K S, LANGGUTH P, LENNERNAS H, et al. Bioequivalence of oral products and the biopharmaceutics lassification system: science, regulation, and public policy [ J ]. Clin Pharmacol Ther,2011,90 ( 3 ) : 467-470.
  • 9OM A, LAWRENCE X Y, DALE P,et al. Dissolution tes- ting for generic drugs: An FDA perspective [ J]. AAPS J, 2011,13 (3) :328-335.
  • 10JEREMY A, GREEN E,AARON S. Why do the same drugs look different? pills, trade dress, and public health[ J ]. N Eengl J Med ,2011,365 ( 1 ) : 83-89.

引证文献6

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部